A

Anthem Capital

10 employees

Anthem Capital Management is an early stage venture firm that invests in companies in the mid-Atlantic states.

Investor insights

Countries invested in

united states1

Sectors invested in

Health Care6
Biotechnology5
carbohydrate chemistry4
orphan drugs4
small molecule drugs4
Therapeutics4
Analytics2
Mobile2
Life Science2
Master Data Management (MDM) Enterprise Software Provider2
active implantable medical device1
Content Management1
Music1
video1
TV1
Digital Media1
Content syndication1
Broadcasting1
Wearables1
continuous glucose monitor1

Funding rounds participated in

$7.8M sweet spot round size

Most of their 22 investments are in rounds between $5.5M and $20M

Basic info

Industry

facilities services

Sectors

Enterprise Software
Mobile
Venture Capital

Date founded

1994

Investments made

S

Senseonics, Inc. raised $20M on June 5, 2014

Investors: Greenspring Associates, Rho Ventures, Abingworth, HealthCare Ventures LLC and Anthem Capital

G

GlycoMimetics raised $38M on December 7, 2009

Investors: Sanofi Ventures, Alliance ventures and Anthem Capital

S

Siperian, Inc. raised $25M on January 22, 2008

Investors: ARROWPATH VENTURE MANAGEMENT LLC, Capital Growth Investments Inc, REV Venture Partners, Brightspark Ventures, Anthem Venture Partners, Blumberg Capital, Saffron Hill Ventures and Anthem Capital

R

Redlasso raised $6.9M on November 1, 2007

Investors: Guggenheim Partners and Anthem Capital

U

Undisclosed raised $7M on March 27, 2007

Investors: Intersouth Partners and Anthem Capital

G

GlycoMimetics raised $15M on June 23, 2006

Investors: PTV Healthcare Capital, Alliance ventures and Anthem Capital

U

Undisclosed raised $7.2M on June 8, 2006

Investors: Canaan and Anthem Capital

T

Triumfant, Inc raised $6M on March 2, 2006

Investors: Inflection Point Ventures, - and Anthem Capital

U

Undisclosed raised $11M on July 14, 2005

Investors: BioAdvance, Domain Associates and Anthem Capital

U

Undisclosed raised $3.6M on April 26, 2005

Investors: Intersouth Partners and Anthem Capital

FAQ